Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.95 |
| ▸ | CES1 | P23141 | 6/20 | 0.50 |
| ▸ | CES2 | O00748 | 5/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KDM5A | P29375 | 6/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | KDM5C | P41229 | 1/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.40 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9210592 | 0.97 | — | — | |
| SCHEMBL827843 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL14895307 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES1CES2CHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL29184598 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES1CES2CHRNB2CHRNB4 | |
| SCHEMBL630064 | 0.90 | ALDH1A1 (0.85) | ALDH1A1CES1CES2CHRNB2CHRNB4 | |
| Hexadecanoic Acid Dimethylamide SCHEMBL148603 | 0.87 | ALDH1A1 (0.81) | ALDH1A1CES1CES2AKR1B1 | |
| SCHEMBL2486021 | 0.87 | ALDH1A1 (0.81) | ALDH1A1CES1CES2AKR1B1 | |
| SCHEMBL740728 | 0.87 | ALDH1A1 (0.81) | ALDH1A1CES1CES2AKR1B1 | |
| SCHEMBL22406917 | 0.87 | ALDH1A1 (0.81) | ALDH1A1CES1CES2AKR1B1 | |
| SCHEMBL2090517 | 0.87 | ALDH1A1 (0.81) | ALDH1A1CES1CES2AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5284975-A | Method of preparing α-d-phenylalkylbenzyl carbinol | MALLINCKRODT SPECIALTY CHEMICALS COMPANY (US) | 1994-02-08 | — | — | US | claimed |
| US-20200315929-A1 | OIL-IN-WATER TYPE EMULSION SOLID COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2020-10-08 | — | — | US | disclosed |
| US-5284975-A | Method of preparing α-d-phenylalkylbenzyl carbinol | MALLINCKRODT SPECIALTY CHEMICALS COMPANY (US) | 1994-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200315929-A1 | OIL-IN-WATER TYPE EMULSION SOLID COSMETIC | CUTA, MUC1, SMARCA1 | ALDH1A1 89/4885CES1 549/4885CES2 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.